- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02785367
Changes of Gas Values in Cord Blood Versus Time and Temperature
Study Overview
Detailed Description
The PH levels of a neonatal in his birth are an important factor in establishing the connection between events that occurred during the actual time of birth, to the risk of a significant morbidity development in the future. Gas values in cord blood are measurable and represent the condition of the fetus close to the time of birth. Their level is one of the essential criteria which are used to define acute hypoxic event during birth. As the oxygen supply to the fetus significantly disturbed, deficiency of oxygen in the tissues is growing. Therefore, the tissues begin to accumulate large amounts of acid and thereby developing fetal blood acidosis. Many works connected the presence of cord blood acidosis to development of neonatal cerebral palsy. According to the American Association of Obstetrics and Gynecology, cord blood gas sample is necessary when a prenatal event may be related (rightly or not) with negative neonatal outcome. This approach might be necessary when the case is legally controversial and there is a need to prove that umbilical cord gas values were normal at the pre-natal period.
Aim of study Our aim is to find the effect of the cord blood sample storage way, and the effect of the sample taking time from the delivery.
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Gestational age 37 weeks and above. Vaginal or cesarean births.
Exclusion Criteria:
Women who had medical indication to cord blood sample taking for gas measurement (Apgar<7 in the 5th minute, premature labor (under 37 weeks), multiple pregnancy, vacuum birth, urgent cesarean
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cord blood samples
8 cord blood samples will be taken from the umbilical cord in 8 syringes of about 3 ml washed with Heparin.
|
After delivery, 8 cord blood samples will be taken from the umbilical cord in 8 syringes of about 3 ml, washed with Heparin (Designated syringes exist in the delivery room). 4 syringes will be stored in room temperature. Thermometer will be attached to any sample, and temperature values will be indicated before any measurement. The samples will be measured in a gas measurement device, in 4 time points: at the birth, after 15 minutes, after 30 minutes and after 60 minutes from the birth. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
gas values
Time Frame: 60 minutes
|
gas(pH) values will be examined at different times after the birth.
|
60 minutes
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 0042-46-tlv
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abnormal; Birth
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedIron, Abnormal Blood Level | Other Abnormal Blood ChemistryUnited States
-
Croma-Pharma GmbHCompleted
-
University of WashingtonCompleted
-
CHU de ReimsCompletedAbnormal CytologyFrance
-
University Hospital Inselspital, BerneCompleted
-
University of California, IrvineUnited States Department of DefenseRecruitingAbnormal Vascular FlowUnited States
-
Wolfson Medical CenterUnknown
-
SanofiCompleted
-
Geisinger ClinicCompleted
-
Case Comprehensive Cancer CenterCompletedAbnormal Breast TissueUnited States
Clinical Trials on Cord blood samples
-
Konya City HospitalCompleted
-
MinYoung Kim, M.D.Completed
-
Bundang CHA HospitalWithdrawnCerebral PalsyKorea, Republic of
-
Bundang CHA HospitalWithdrawn
-
MinYoung Kim, M.D.CompletedGlobal Developmental DelayKorea, Republic of
-
University of Colorado, DenverRecruiting
-
MinYoung Kim, M.D.Completed
-
Centre Georges Francois LeclercINSERM U866 Faculté de Médecine et PharmacieCompleted
-
Centre Hospitalier Universitaire DijonCompletedPrimary Immune Thrombocytopenia (ITP)France